Selective targeting of bioengineered platelets to prostate cancer vasculature: new paradigm for therapeutic modalities-Reference-Cited by-同舟云学术

Selective targeting of bioengineered platelets to prostate cancer vasculature: new paradigm for therapeutic modalities

Published:2015-03-04 Issue:7 Volume:19 Page:1530-1537
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Montecinos Viviana P.¹,Morales Claudio H.²³,Fischer Thomas H.⁴,Burns Sarah⁵,San Francisco Ignacio F.⁶,Godoy Alejandro S.²⁷,Smith Gary J.²

Affiliation:

1. Department of Hematology‐Oncology Pontificia Universidad Católica de Chile Santiago Chile

2. Department of Urology Roswell Park Cancer Institute Buffalo NY USA

3. Hospital Clínico Dr. Félix Bulnes Cerda Servicio de Salud Metropolitano Occidente Santiago Chile

4. Department of Pathology and Laboratory Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA

5. Department of Medicine Roswell Park Cancer Institute Buffalo NY USA

6. Department of Urology Pontificia Universidad Católica de Chile Santiago Chile

7. Department of Physiology Pontificia Universidad Católica de Chile Santiago Chile

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.12515

Reference23 articles.

1. Tumor Angiogenesis: Therapeutic Implications

2. Correction: Antiangiogenic therapy: impact on invasion, disease progression, and metastasis

3. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

4. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation;1Vartanian RK;Lab Invest,1995

5. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma;Weidner N;Am J Pathol,1993

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances of Iron Oxide Nanoparticles-Based Nanomedicine for Prostate Cancer (Review);Molecular Biomarkers for Cancer Diagnosis and Therapy;2024

2. An Overview of the Latest Applications of Platelet-Derived Microparticles and Nanoparticles in Medical Technology 2010-2020;Current Molecular Medicine;2021-09-28

3. Biopolymer and Biomaterial Conjugated Iron Oxide Nanomaterials as Prostate Cancer Theranostic Agents: A Comprehensive Review;Symmetry;2021-05-31

4. Engineered nanomedicines for tumor vasculature blockade therapy;WIREs Nanomedicine and Nanobiotechnology;2021-01-21

5. Gene Therapy for Platelet Disorders;Platelets;2019